Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001209191-22-011049 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-02-17	2022-02-15+	ELVN	MOTT DAVID M	Dir	P - Purchase	$1.19	+45.9K	63.2K	+267%	+$54.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-17	P	A	14,595	$1.17	77,752	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F4) Open market purchases reported on this line occurred at a weighted average price of $1.17 (range $1.15 to $1.21).
2	Common	Common Stock	2022-02-15	P	A	19,552	$1.20	51,378	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F1) Open market purchases reported on this line occurred at a weighted average price of $1.20 (range $1.16 to $1.26).
3	Common	Common Stock	2022-02-16	P	A	11,779	$1.20	63,157	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F3) Open market purchases reported on this line occurred at a weighted average price of $1.20 (range $1.17 to $1.23).